![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1875-5607|13|11|1564-1571
ISSN: 1389-5575
Source: Mini Reviews in Medicinal Chemistry, Vol.13, Iss.11, 2013-10, pp. : 1564-1571
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Mittal R.D. Mishra D.K. Bid H.K. Mandhani A.
UroOncology, Vol. 4, Iss. 3-4, 2004-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Treatment options for benign prostatic hyperplasia
By Thurlow R.J.
Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Dutasteride for the treatment of benign prostatic hyperplasia
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Dutasteride/Tamsulosin: In Benign Prostatic Hyperplasia
Drugs & Aging, Vol. 29, Iss. 5, 2012-05 ,pp. :